slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,71 USD | +7,11% | -4,58% | +52,25% |
25/03 | ProKidney Corp. Kondigt belangrijke benoemingen van leidinggevenden aan ter versterking van klinische en technische operaties | CI |
22/03 | ProKidney boekt groter verlies in 2023 | MT |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 167 mln. 156 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -157 mln. -147 mln. | Nettowinst (verlies) 2025 * | -40 mln. -37,36 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 152 mln. 142 mln. | Nettoliquiditeiten 2025 * | 295 mln. 276 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-1,86
x | K/w-verhouding 2025 * |
-6,95
x | Werknemers | 163 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,02% |
Recentste transcriptie over ProKidney Corp.
1 dag | +7,11% | ||
1 week | -4,58% | ||
Lopende maand | +65,24% | ||
1 maand | +93,57% | ||
3 maanden | +67,28% | ||
6 maanden | +47,28% | ||
Lopend jaar | +52,25% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bruce Culleton
CEO | Chief Executive Officer | 57 | 17-07-23 |
James Coulston
DFI | Director of Finance/CFO | 48 | 01-01-22 |
Joseph Stavas
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-10-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bill Doyle
BRD | Director/Board Member | 61 | 01-01-22 |
Brian Pereira
BRD | Director/Board Member | 65 | 01-01-22 |
John Maraganore
BRD | Director/Board Member | 60 | 11-08-22 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,35% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 2,71 | +7,11% | 538 370 |
23-04-24 | 2,53 | -6,99% | 1 152 575 |
22-04-24 | 2,72 | +33,33% | 2 804 606 |
19-04-24 | 2,04 | -15,00% | 783 634 |
18-04-24 | 2,4 | -15,49% | 1 505 649 |
slotkoers Nasdaq, 24 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+52,25% | 156 mln. | |
+4,09% | 43,43 mld. | |
+47,81% | 41,69 mld. | |
+9,45% | 41,31 mld. | |
-10,92% | 27,14 mld. | |
+9,32% | 25,28 mld. | |
-24,87% | 18,47 mld. | |
+29,70% | 12,59 mld. | |
+1,28% | 12,33 mld. | |
+7,78% | 11,03 mld. |